Showing results (1371-1380 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|June 13, 2022
Indications and effects of biological agents in the treatment of noninfectious uveitisBowen Li, Li Yang, Feng Bai, et al.
Immunotherapy|June 13, 2022
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profilingKevin Tyan, Osama Abu-Shawer, Joanna Baginska, et al.
Immunotherapy|June 13, 2022
First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancerDaniele Mengato, Luca Cancanelli, Melania Rivano, et al.
Immunotherapy|June 14, 2022
Immunotherapy in advanced non-small-cell lung cancer (NSCLC) after progression on chemotherapy: real-world results from a prospective institutional cohortUllas Batra, Kundan Singh Chufal, Shrinidhi Nathany, et al.
Immunotherapy|June 9, 2022
Treatment of EAE mice with Treg, G-MDSC and IL-2: a new insight into cell therapy for multiple sclerosisMohammad Mehdi Ghorbani, Touraj Farazmandfar, Saeid Abediankenari, et al.
Immunotherapy|December 5, 2022
Human growth hormone supplement promotes human lymphohematopoietic cell reconstitution in immunodeficient miceSiwen Zhang, Guixia Wang, Yanan Lyu, et al.
Immunotherapy|December 6, 2022
Fractional exhaled nitric oxide in checkpoint inhibitor pneumonitis: a case report and literature reviewChen Wu, Weiying Liu, Jiayuan Pu, et al.
Immunotherapy|June 27, 2022
Cost-effectiveness analysis of nivolumab plus cabozantinib versus sunitinib as first-line therapy in advanced renal cell carcinomaRuizhe Liu, Kaifeng Qiu, Junyan Wu, et al.
Immunotherapy|May 5, 2022
A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposisMatthew J Lelegren, Sam Y Son, Joseph K Han, et al.
Immunotherapy|May 24, 2019
Monitoring efficacy of checkpoint inhibitor therapy in patients with non-small-cell lung cancerAnnett Schiwitza, Hans-Ulrich Schildhaus, Birgit Zwerger, et al.
Pageof 188